00648 京玖康療－新
按盘价 
0.380 0.000 (0.000%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | 589.339% | 31.001% | -87.876% | -113.225% | -147.363% |
| 股东资金回报率 (%) | N/A | N/A | N/A | N/A | N/A |
| 资本运用回报率 (%) | 10851.912% | N/A | N/A | N/A | N/A |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 33.672% | 41.147% | 40.684% | 46.498% | 54.331% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 603.377% | 54.801% | 2.722% | -427.016% | -341.032% |
| 税前边际利润率 (%) | 600.220% | 27.988% | -49.258% | -1454.797% | -545.596% |
| 纯利率 (%) | 597.224% | 24.369% | -56.938% | -1546.498% | -528.710% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 0.964 X | 0.093 X | 0.051 X | 0.045 X | 0.094 X |
| 速动比率 (X) | 0.872 X | 0.086 X | 0.045 X | 0.045 X | 0.067 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 95.507% | 677.570% | 1495.921% | 1799.885% | 1258.746% |
| 总债项 / 总资产比率 (%) | 62.244% | 518.991% | 1122.252% | 1428.370% | 958.688% |
| 净债项 / 总资产比率 (%) | 46.196% | 504.603% | 1109.688% | 1409.166% | 954.757% |
| 总债项 / 股东资金比率 (%) | 1385.464% | N/A | N/A | N/A | N/A |
| 长期债项 / 股东资金比率 (%) | 22.435% | N/A | N/A | N/A | N/A |
| 净债项 / 股东资金比率 (%) | 1028.257% | N/A | N/A | N/A | N/A |
| 净现金 / (债项) ($) | (2.53千万) | (2.83亿) | (2.73亿) | (2.69亿) | (2.61亿) |
| 每股净现金 / (债项) ($) | (0.077) | (0.868) | (0.839) | (0.826) | (0.799) |
| 总债项 / 资本运用比率 (%) | 1131.593% | N/A | N/A | N/A | N/A |
| 利息盈利率 (X) | 249.262 X | 2.110 X | N/A | N/A | N/A |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | 38.327日 | 28.992日 | 35.902日 | N/A | 528.967日 |
| 应收贸易帐周转率日数 (日) | 79.651日 | 28.953日 | 14.604日 | 195.712日 | 19.508日 |
| 应付贸易帐周转率日数 (日) | 67.343日 | N/A | N/A | N/A | 171.171日 |
| 备注： | 实时报价更新时间为31/10/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
